UK markets closed

Eliem Therapeutics, Inc. (ELYM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.81+0.12 (+1.38%)
At close: 04:00PM EDT
8.91 +0.10 (+1.14%)
After hours: 04:02PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
10,782
15,411
26,214
23,322
9,342
-
Selling general and administrative
9,060
24,864
18,921
12,350
2,425
-
Total operating expenses
19,842
40,275
45,135
35,672
11,767
-
Operating income or loss
-19,842
-40,275
-45,135
-35,672
-11,767
-
Total other income/expenses net
255
536
-1,484
-11,808
-8,901
-
Income before tax
-14,526
-35,119
-45,244
-47,480
-20,668
-
Income from continuing operations
-14,526
-35,119
-45,244
-47,480
-20,668
-
Net income
-14,526
-35,119
-45,244
-47,480
-20,668
-
Net income available to common shareholders
-14,526
-35,119
-45,244
-52,028
-22,953
-
Basic EPS
-1.46
-
-1.72
-4.24
-1.97
-1.08
Diluted EPS
-1.46
-
-1.72
-4.24
-1.97
-1.08
Basic average shares
26,696
-
26,312
12,261
11,662
6,837
Diluted average shares
26,696
-
26,312
12,261
11,662
6,837